China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Prospective, Phase II Study of TROP-2 ADC in Combination with Toripalimab for Resectable Locally Advanced Oral Squamous Cell Carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600129814
Registration Time: 2026/08/10
Type: Interventional study
Primary Sponsor: Shanghai East Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=335688
Published by HT Digital Content Services with permission from Health Daily Digest....